+44 (0) 1698 534002
Contact

Posters

From Screening to Validation: A Comprehensive Approach to Identifying Covalent Inhibitors for Challenging Targets

Go to poster

Identification and Characterisation of Fragment Molecules Binding to Hpgk1 Using Complementary Biophysical Techniques

Go to poster

FLIPR Assay Screen of a 5K Compound Library to Identify Potential Positive Allosteric Modulators of 5-HT2A Receptors

Go to poster

Automated Multiplex Pooling of Large Compound Libraries for ASMS Screening

Go to poster

The European Lead Factory: A Collaborative Approach to Drug Discovery

Go to poster

The SULSA Assay Development Fund: a model for widening access to high throughput screening

Go to poster

Characterization of small molecule inhibitors of the Nrf2-Keap1 interaction using MicroScale Thermophoresis

Go to poster

The use of Dynamic Mass Redistribution (DMR) in the European Lead Factory (ELF): a case study

Go to poster

Using a library of Pan-Assay Interference (PAINS) small molecules to understand and improve HTS outcomes

Go to poster

Using label-free technologies to characterise the pharmacology of the mas-related GPCR family member D (MRGPRD) receptor

Go to poster

Discovery and Characterisation of a Novel TRPML1 Agonist

Go to poster

Advancing Drug Discovery: Facilitating AI-driven Initiatives with Automation in BioAscent’s Centralised Compound Management

Go to poster

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact